Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis

European Journal of Ophthalmology

Volumn 8, Issue 4, 1998, Pages 207-216

  Richard, C ^a   Trinquand, C ^a   Bloch Michel, E ^a   Favennec, F ^a   Hellebold, L ^a   Hofmann, B ^a   Lecorvec, M P ^a   Verin, P ^a   Zech, J C ^a  

^a Laboratoire Chauvin   (France)

Author keywords

Allergic conjunctivitis; Eyedrops; Levocabastine; Lodoxamide

Indexed keywords

EYE DROPS; LEVOCABASTINE; LODOXAMIDE; PLACEBO;

ADOLESCENT; ADULT; AGED; ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL DEGRANULATION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; SCORING SYSTEM; TOPICAL DRUG ADMINISTRATION;

EID: 0032448928     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219800800402     Document Type: Article

References (25)